Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review
Open Access
- 12 December 2014
- journal article
- review article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 143 (9) , 1791-1802
Abstract
SUMMARY: A systematic literature review was performed on full economic evaluations of infectious disease interventions using disability-adjusted life years (DALY) as outcome measure. The search was limited to the period between 1994 and September 2011 and conducted in Medline, SciSearch and EMBASE databases. We included 154 studies, mostly targeting HIV/AIDS and malaria with most conducted for African countries (40%) and <10% in high-income countries. Third-payer perspective was applied in 29% of the studies, 25% used the societal perspective and 12% used both. Only 16% of the studies took indirect effects (i.e. herd immunity) of interventions into account. Intervention, direct healthcare and indirect non-healthcare costs were taken into account in respectively 100%, 81% and 36% of the studies. The majority of the studies followed the Global Burden of Disease method for DALY estimations, but most studies deviated from WHO cost-effectiveness guidelines. Better adherence to freely accessible guidelines will improve generalizability between full economic evaluations.Keywords
This publication has 38 references indexed in Scilit:
- The Pathogen- and Incidence-Based DALY Approach: An Appropriated Methodology for Estimating the Burden of Infectious DiseasesPLOS ONE, 2013
- Methodological reviews of economic evaluations in health care: what do they target?The European Journal of Health Economics, 2013
- New Methodology for Estimating the Burden of Infectious Diseases in EuropePLOS Medicine, 2012
- Methodological Quality of Economic Evaluations of New Pharmaceuticals in the NetherlandsPharmacoEconomics, 2012
- Modelling the Epidemiology of Infectious Diseases for Decision AnalysisPharmacoEconomics, 2011
- Costing and Perspective in Published Cost-Effectiveness AnalysisMedical Care, 2009
- Cost-effectiveness of Rotavirus vaccination in VietnamBMC Public Health, 2009
- When should decision-analytic modeling be used in the economic evaluation of health care?The European Journal of Health Economics, 2003
- Cost‐effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in UgandaHealth Economics, 1995
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995